Cargando…

“Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficit, hyperactivity, and impulsivity. Jing-Ning Granules (JNG) is a traditional Chinese medicine (TCM) that can alleviate ADHD. Although JNG is commonly used for the effective t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jie, Ding, Yiyun, Wu, Jingjing, Deng, Jialin, Yu, Qingyang, Wang, Junhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635972/
https://www.ncbi.nlm.nih.gov/pubmed/36337583
http://dx.doi.org/10.1155/2022/9139841
_version_ 1784824834688024576
author Ding, Jie
Ding, Yiyun
Wu, Jingjing
Deng, Jialin
Yu, Qingyang
Wang, Junhong
author_facet Ding, Jie
Ding, Yiyun
Wu, Jingjing
Deng, Jialin
Yu, Qingyang
Wang, Junhong
author_sort Ding, Jie
collection PubMed
description BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficit, hyperactivity, and impulsivity. Jing-Ning Granules (JNG) is a traditional Chinese medicine (TCM) that can alleviate ADHD. Although JNG is commonly used for the effective treatment of ADHD and has obtained the national invention patent, the exact mechanism of action remains unclear. OBJECTIVE: In this study, we examined the effect and mechanism of JNG in spontaneously hypertensive rats (SHRs). We hypothesized that JNG affects dopaminergic D2/D1-like receptors and related pathways. MATERIALS AND METHODS: Six rat groups were used in the experiment: Wistar-Kyoto rats (WKY, control group) and five SHR groups, including a model group; atomoxetine (ATX, positive control) group; and low, medium, and high-dose JNG groups. The corresponding treatments were daily administered to each group for 6 weeks. A behavioral test, including a step-down test and open field test (OFT), was carried out at the end of treatment. After the behavioral test, all animals were sacrificed, and the brain tissue was collected and analyzed ex vivo; histopathological analysis was performed to assess the pathological changes of the hippocampus; expression of D1-like and D2-like receptors, sensor protein calmodulin (CaM), protein kinase A (PKA), and calcium/calmodulin-dependent serine/threonine protein kinase (CaMKII) in the striatum and hippocampus was measured by western blot and real-time quantitative PCR (RT-PCR); cyclic adenosine monophosphate (cAMP) levels in the striatum were analyzed using an enzyme-linked immunosorbent assay (ELISA), while the level of Ca(2+) in the striatum was analyzed by a calcium kit. RESULTS: Our results showed that ATX or JNG could ameliorate the hyperactive/impulsive behavior and cognitive function of ADHD by promoting neuroprotection. Mechanistically, ATX or JNG could prompt the expressions of Dl-like and D2-like receptors and improve the mRNA and protein levels of cAMP/PKA and Ca(2+)/CAM/CAMKII signaling pathways. CONCLUSION: These results indicate that JNG can produce therapeutic effects by regulating the balance of D2/D1-like receptor-mediated cAMP/PKA and Ca(2+)/CaM/CaMKII signaling pathways.
format Online
Article
Text
id pubmed-9635972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-96359722022-11-05 “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways Ding, Jie Ding, Yiyun Wu, Jingjing Deng, Jialin Yu, Qingyang Wang, Junhong Evid Based Complement Alternat Med Research Article BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by attention deficit, hyperactivity, and impulsivity. Jing-Ning Granules (JNG) is a traditional Chinese medicine (TCM) that can alleviate ADHD. Although JNG is commonly used for the effective treatment of ADHD and has obtained the national invention patent, the exact mechanism of action remains unclear. OBJECTIVE: In this study, we examined the effect and mechanism of JNG in spontaneously hypertensive rats (SHRs). We hypothesized that JNG affects dopaminergic D2/D1-like receptors and related pathways. MATERIALS AND METHODS: Six rat groups were used in the experiment: Wistar-Kyoto rats (WKY, control group) and five SHR groups, including a model group; atomoxetine (ATX, positive control) group; and low, medium, and high-dose JNG groups. The corresponding treatments were daily administered to each group for 6 weeks. A behavioral test, including a step-down test and open field test (OFT), was carried out at the end of treatment. After the behavioral test, all animals were sacrificed, and the brain tissue was collected and analyzed ex vivo; histopathological analysis was performed to assess the pathological changes of the hippocampus; expression of D1-like and D2-like receptors, sensor protein calmodulin (CaM), protein kinase A (PKA), and calcium/calmodulin-dependent serine/threonine protein kinase (CaMKII) in the striatum and hippocampus was measured by western blot and real-time quantitative PCR (RT-PCR); cyclic adenosine monophosphate (cAMP) levels in the striatum were analyzed using an enzyme-linked immunosorbent assay (ELISA), while the level of Ca(2+) in the striatum was analyzed by a calcium kit. RESULTS: Our results showed that ATX or JNG could ameliorate the hyperactive/impulsive behavior and cognitive function of ADHD by promoting neuroprotection. Mechanistically, ATX or JNG could prompt the expressions of Dl-like and D2-like receptors and improve the mRNA and protein levels of cAMP/PKA and Ca(2+)/CAM/CAMKII signaling pathways. CONCLUSION: These results indicate that JNG can produce therapeutic effects by regulating the balance of D2/D1-like receptor-mediated cAMP/PKA and Ca(2+)/CaM/CaMKII signaling pathways. Hindawi 2022-10-28 /pmc/articles/PMC9635972/ /pubmed/36337583 http://dx.doi.org/10.1155/2022/9139841 Text en Copyright © 2022 Jie Ding et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ding, Jie
Ding, Yiyun
Wu, Jingjing
Deng, Jialin
Yu, Qingyang
Wang, Junhong
“Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways
title “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways
title_full “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways
title_fullStr “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways
title_full_unstemmed “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways
title_short “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways
title_sort “jing-ning granules” can alleviate attention deficit hyperactivity disorder in rats by modulating dopaminergic d2/d1-like receptor-mediated signaling pathways
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635972/
https://www.ncbi.nlm.nih.gov/pubmed/36337583
http://dx.doi.org/10.1155/2022/9139841
work_keys_str_mv AT dingjie jingninggranulescanalleviateattentiondeficithyperactivitydisorderinratsbymodulatingdopaminergicd2d1likereceptormediatedsignalingpathways
AT dingyiyun jingninggranulescanalleviateattentiondeficithyperactivitydisorderinratsbymodulatingdopaminergicd2d1likereceptormediatedsignalingpathways
AT wujingjing jingninggranulescanalleviateattentiondeficithyperactivitydisorderinratsbymodulatingdopaminergicd2d1likereceptormediatedsignalingpathways
AT dengjialin jingninggranulescanalleviateattentiondeficithyperactivitydisorderinratsbymodulatingdopaminergicd2d1likereceptormediatedsignalingpathways
AT yuqingyang jingninggranulescanalleviateattentiondeficithyperactivitydisorderinratsbymodulatingdopaminergicd2d1likereceptormediatedsignalingpathways
AT wangjunhong jingninggranulescanalleviateattentiondeficithyperactivitydisorderinratsbymodulatingdopaminergicd2d1likereceptormediatedsignalingpathways